On 3 March, DGFT had restricted export of paracetamol and about a dozen other APIs as well as their formulations amid concern over supply disruption of crucial raw materials amid the Covid-19 pandemic NEW DELHI: The Directorate General of Foreign Trade has lifted restrictions on export of active pharmaceutical ingredient (API) of popular antipyretic drug paracetamol, almost three months after the curbs were put in place due to shortage of supply from China amid the Covid-19 pandemic. “The notification...
is further amended to remove restriction on export of paracetamol APIs, making its export ‘free’ with immediate effect," the trade watchdog said in a notification on Thursday.